Your browser doesn't support javascript.
loading
Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT).
Maffini, Enrico; Labopin, Myriam; Beelen, Dietrich Wilhelm; Kroeger, Nicolaus; Arat, Mutlu; Wilson, Keith M O; Bay, Jacques-Olivier; Ganser, Arnold; Martin, Hans; Passweg, Jakob; Kottaridis, Panagiotis D; Yakoub-Agha, Ibrahim; Porras, Rocio Parody; Wagner, Eva Maria; Esteve, Jordi; Lanza, Francesco; Nagler, Arnon; Mohty, Mohamad.
Afiliación
  • Maffini E; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Istituto "L. e A. Seràgnoli", Bologna, Italy. enrico.maffini@aosp.bo.it.
  • Labopin M; EBMT Paris Study Office, Department of Hematology and Cell Therapy, Hôpital Saint-Antoine, Paris, France.
  • Beelen DW; West German Cancer Center, University Hospital of Essen, Essen, Germany.
  • Kroeger N; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Arat M; Sisli Florence Nightingale Hospital, Istanbul, Turkey.
  • Wilson KMO; Hematology, University of Wales, Cardiff, UK.
  • Bay JO; Centre Jaen Perrin, Clermont-Ferrand, France.
  • Ganser A; Medizinische Hochschule Hannover, Hannover, Germany.
  • Martin H; Medizinische Klinik II: Hämatologie und Onkologie, Goethe Universitat, Frankfurt am Main, Germany.
  • Passweg J; Division of Hematology, University Hospital Basel, Basel, Switzerland.
  • Kottaridis PD; University College London Hospital NHS FT, London, United Kingdom.
  • Yakoub-Agha I; CHU de Lille, UNIV Lille, INSERM U1286, Infinite, 59000, Lille, France.
  • Porras RP; Instituto Catalá de Oncología Hospitalet, Barcelona, Barcelona, Spain.
  • Wagner EM; Department of Hematology, Medical Oncology and Pneumology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
  • Esteve J; Hospital Clínic of Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Lanza F; Hematology Unit, Transplant Network, Ravenna, Italy.
  • Nagler A; EBMT Paris Study Office, Department of Hematology and Cell Therapy, Hôpital Saint-Antoine, Paris, France.
  • Mohty M; Hematology and Bone Marrow Transplantation Division, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
Bone Marrow Transplant ; 57(10): 1556-1563, 2022 10.
Article en En | MEDLINE | ID: mdl-35835997
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Neoplasias Primarias Secundarias / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2022 Tipo del documento: Article País de afiliación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Neoplasias Primarias Secundarias / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2022 Tipo del documento: Article País de afiliación: Italia